Shares of Johnson & Johnson (NYSE:JNJ) ended Wednesday session in red amid volatile trading. The shares closed down -0.14 points or -0.12% at $119.61 with 4.75 million shares getting traded. Post opening the session at $119.84, the shares hit an intraday low of $119.43 and an intraday high of $119.95 and the price vacillated in this range throughout the day. The company has a market cap of $328.42 billion and the numbers of outstanding shares have been calculated to be 2.74 billion shares.
On Sept. 7, 2016 Johnson & Johnson is partnering with social action platform Global Citizen to help give every man, woman and child around the globe the opportunity for a healthier future. The partnership aims to create large-scale change for health systems through integrated solutions to help solve the world’s most pressing public health challenges.
“Good health is the cornerstone for a happy, fulfilling life,” said Lauren Moore, Johnson & Johnson Vice President of Corporate Citizenship. “Johnson & Johnson believes it is essential that we take a leading role in helping to build a future in which people everywhere have an equal opportunity to access quality healthcare, right from the very start. Through this partnership with Global Citizen, we hope to elevate awareness of the importance of strong public health programs and to also inspire others to join this global effort.”
The Johnson & Johnson-Global Citizen health campaign will focus on maternal and child health, particularly prenatal health care, child immunization targets and HIV and polio eradication. Through a combination of on-the-ground efforts, multimedia content and consumer activations, the campaign focuses on engaging people to take simple actions to support these causes. Starting and lasting for two weeks, citizens who want to create change can download the free Global Citizen app and participate in a range of actions for the opportunity to receive tickets to the Global Citizen Festival on September 24.
Shares of Bristol-Myers Squibb Co (NYSE:BMY) ended Wednesday session in red amid volatile trading. The shares closed down -0.40 points or -0.69% at $56.57 with 11.72 million shares getting traded. Post opening the session at $57.02, the shares hit an intraday low of $56.42 and an intraday high of $57.45 and the price vacillated in this range throughout the day. The company has a market cap of $95.54 billion and the numbers of outstanding shares have been calculated to be 1.66 billion shares.
Bristol-Myers Squibb Co (BMY) announced that it will present at the Bank of America Merrill Lynch Global Health Care Conference on Wednesday, September 14, 2016, in London. John Elicker, senior vice president, Public Affairs and Investor Relations, will make a formal presentation about the company at 1 p.m. BST (8 a.m. EDT).
Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.